Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors

Journal of Proteomics

Volumn 78, Issue , 2013, Pages 231-244

  Habif, Guillaume ^a   Grasset, Marie France ^a   Kieffer Jaquinod, Sylvie ^b   Kuhn, Lauriane ^b   Mouchiroud, Guy ^a   Gobert Gosse, Stéphanie ^a  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

Author keywords

Cytoskeleton; Flt3; Leukemia; Proliferation; Signaling

Indexed keywords

COMPLEMENTARY DNA; EZRIN; FLT3 LIGAND; HCLS1 PROTEIN; P21 ACTIVATED KINASE 1; RETROVIRUS VECTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL PROLIFERATION; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RETROVIRUS INFECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOOD PROTEINS; CELL LINE; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID, ACUTE; MEMBRANE PROTEINS; MICE; MUTATION; MYELOID PROGENITOR CELLS; NEOPLASTIC STEM CELLS; P21-ACTIVATED KINASES; PHOSPHOPROTEINS; PROTEOME; REPETITIVE SEQUENCES, NUCLEIC ACID;

MURINAE;

EID: 84872679912     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.09.009     Document Type: Article

References (36)

1. Gilliland D.G., Griffin J.D. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002, 5:1532-1542.
2. Stirewalt D.L., Radich J.P. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 2003, 9:650-665.
3. Mackarehtschian K., Hardin J.D., Moore K.A., Boast S., Goff S.P., Lemischka I.R. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995, 3:147-161.
4. Drexler H.G., Quentmeier H. FLT3: receptor and ligand. Growth Factors 2004, 22:71-73.
5. Fröhling S., Scholl C., Gilliland D.G., Levine R.L. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005, 23:6285-6295.
6. Meshinchi S., Appelbaum F.R. Structural and functional alterations of FLT3 in acute myeloid leukemia. Clin Cancer Res 2009, 15:4263-4269.
7. Riccioni R., Pelosi E., Riti V., Castelli G., Lo-Coco F., Testa U. Immunophenotypic features of AML patients exhibiting high Flt3 expression not associated with mutations. Br J Haematol 2011, 153:33-42.
8. Li L., Piloto O., Nguyen H.B., Greenberg K., Takamiya K., Racke F., et al. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. Blood 2008, 111:3849-3858.
9. Lee B.H., Tothova Z., Levine R.L., Anderson K., Buza-Vidas N., Cullen D.E., et al. Cancer Cell 2007, 12:367-380.
10. Kharazi S., Mead A.J., Mansour A., Hultquist A., Böiers C., Luc S., et al. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood 2001, 118:3613-3621.
11. Reckzeh K., Bereshchenko O., Mead A., Rehn M., Kharazi S., Jacobsen S.E., et al. Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model. Leukemia Feb 9 2012, [Epub ahead of print]. 10.1038/leu.2012.37.
12. Zheng R., Friedman A.D., Levis M., Li L., Weir E.G., Small D. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression. Blood 2004, 1883-1890.
13. Gilliland D.G., Jordan C.T., Felix C.A. The molecular basis of leukemia. Hematology Am Soc Hematol Educ Program 2004, 80-97.
14. Kiyoi H., Towatari M., Yokota S., Hamaguchi M., Ohno R., Saito H., et al. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 1998, 12:1333-1337.
15. Hayakawa F., Towatari M., Kiyoi H., Tanimoto M., Kitamura T., Saito H., et al. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene 2000, 19:624-631.
16. Choudhary C., Olsen J.V., Brandts C., Cox J., Reddy P.N.G., Böhmer F.D., et al. Mol Cell 2009, 36:326-339.
17. Mizuki M., Fenski R., Halfter H., Matsumura I., Schmidt R., Müller C., et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood 2000, 96:3907-3914.
18. Bourette R.P., Myles G.M., Carlberg K., Chen A.R., Rohrschneider L.R. Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells. Cell Growth Differ 1995, 631-645.
19. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000, 7:1063-1066.
20. Wang Z.E., Myles G.M., Brandt C.S., Lioubin M.N., Rohrschneider L. Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain. Mol Cell Biol 1993, 13:5348-5359.
21. Monni R., Haddaoui L., Naba A., Gallais I., Arpin M., Mayeux P., et al. Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia. Blood 2008, 3163-3172.
22. Coffin R.S., MacLean A.R., Latchman D.S., Brown S.M. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther. 1996, 3:886-891.
23. Gobert Gosse S., Bourgin C., Liu W.Q., Garbay C., Mouchiroud G. M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity. Cell Signal 2005, 17:1352-1362.
24. Dupierris V., Masselon C., Court M., Kieffer-Jaquinod S., Bruley C. A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa. Bioinformatics, 25, 1980-1. Bioinformatics 2009, 1980-1981.
25. Schmidt-Arras D.E., Böhmer A., Markova B., Choudhary C., Serve H., Böhmer F.D. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol Cell Biol 2005, 25:3690-3703.
26. Schmidt-Arras D., Böhmer S.A., Koch S., Müller J.P., Blei L., Cornils H., et al. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood 2009, 113:3568-3576.
27. + macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol 2002, 3-15.
28. Ong C.C., Jubb A.M., Zhou W., Haverty P.M., Harris A.L., Belvin M., et al. p21-activated kinase 1: PAK'ed with potential. Oncotarget 2011, 2:491-492.
29. Li T., Zhang J., Zhu F., Wen W., Zykova T., Li X., et al. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation. Carcinogenesis 2011, 32:659-666.
30. Yamanashi Y., Fukuda T., Nishizumi H., Inazu T., Higashi K., Kitamura D., et al. Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J Exp Med 1997, 185:1387-1392.
31. Fazioli F., Wong W.T., Ullrich S.J., Sakaguchi K., Appella E., Di Flore P.P. The Ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. Oncogene 1993, 8:1335-1345.
32. Autero M., Heiska L., Rönnstrand L., Vaheri A., Gahmaberg C.G., Carpén O. Ezrin is a substrate for Lck in T cells. FEBS Lett 2003, 535:82-86.
33. Srivastava J., Elliott B.E., Louvard D., Arpin M. Src-dependent Ezrin phosphorylation in adhesion-mediated signaling. Mol Biol Cell 2005, 16:1481-1490.
34. Gomez T.S., McCarney S.D., Carrizosa E., Labno C.M., Comiskey E.O., Nolz J.C., et al. HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity 2006, 6:741-752.
35. Shaffer M.H., Dupree R.S., Zhu P., Saotome I., Schmidt R.F., McClatchey A.I., et al. Ezrin and moesin function together to promote T cell activation. J Immunol 2009, 189:1021-1032.
36. Wang H., Zeng X., Fan Z., Lim B. RhoH plays distinct roles in T-cell migrations induced by different doses of SDF1α. Cell Signal 2010, 22:1022-1032.